MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)*
Finance & Acquisitions: Recursion
Exscientia Plc (NASDAQ: EXAI)
Organization & Developments: Exscientia
Parents
Exscientia Plc (NASDAQ: EXAI)
Children
2020: Exscientia will use its proprietary “Centaur” platform to both scour existing data for therapies that could be used in one of those target areas as well start at the gene level to find and develop novel compounds
2020: Looking to solve public health crises through discovery, Gates Foundation taps AI firm Exscientia to look for answers – Endpoints News
2022: Exscientia plc 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2024: Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Jumps
*Key People: Exscientia
Finance & Acquisitions: Exscientia